This mirrors SSO‐QPOP analyses where the genetic ablation of CHK1 and BRD4 was identified as the most effective combination specific to MYC‐deregulated HCC, highlighting the translatability of SSO‐QPOP target prioritization in identifying clinically actionable targets and combinations. The gene discussed is CHEK1; the disease is hepatocellular carcinoma.